MarketPeel
Insider Trading Intelligence
Pricing
…
JN

James Andrew Nathanielsz

PPCB
CEO/CFO · PROPANC BIOPHARMA, INC. · CIK 0001554937
FILING MIX · LIFETIME100%/0%
BUYS
2
SELLS
0
TOTAL VALUE
$0
COMPANIES
1
ACTIVE SINCE
Aug 2021
HOLDINGS NOW
5,928,004
AVG SELL PX
—
TRADE KIND
SHOWING 2 / 2
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
No backtest data available for James Andrew Nathanielsz. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.
Holdings over time
PPCB · 5,928,004 shares · as of Aug 17, 2021
01,482,0012,964,0024,446,0035,928,004SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2021
FLOW · 2 buys / 0 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
PPCB
PROPANC BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
2,800,000——2,800,000Aug 17, 2021Aug 19, 2021 ↗View →
PPCB
PROPANC BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
5,928,000——5,928,004Aug 17, 2021Aug 19, 2021 ↗View →
Other insiders · PPCB
Loading peer insiders…
About this filer
CIK 0001554937
ROLE
CEO/CFO
PRIMARY
PPCB
COMPANIES
1
ACTIVE SINCE
Aug 2021
MARKETPEEL · /INSIDER/0001554937DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback